We are live on
!
Find out more
Nicholas Company Portfolio holdings
AUM
$5.47B
Turnover
6.8%
1-Year Est. Return
16.96%
This Fund
S&P 500
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
(+1.6%)
Cap. Flow
-$99.3M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$36.1M |
| 2 |
ADT Corp
ADT
|
+$34.9M |
| 3 |
Pfizer
PFE
|
+$27.7M |
| 4 |
Chubb
CB
|
+$19.3M |
| 5 |
Johnson Controls International
JCI
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$79.3M |
| 2 |
MCRS
MICROS SYSTEMS INC
MCRS
|
+$73.6M |
| 3 |
Motorola Solutions
MSI
|
+$51M |
| 4 |
Bausch Health
BHC
|
+$23.5M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.03% |
| 2 | Consumer Discretionary | 15.41% |
| 3 | Industrials | 15.12% |
| 4 | Financials | 11.91% |
| 5 | Technology | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Steris
STE
$21.9B
| $5.59M | 0.13% |
104,465
-105
| -0.1% | -$5.41K |
2013 Q2
4 quarters
|
|
|
CLR
127
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.58M | 0.13% |
70,690
-30,800
| -30% | -$2.14M |
2013 Q2
4 quarters
|
|
128
F5
FFIV
$25.9B
| $5.58M | 0.13% |
50,050
+5,010
| +11% | +$539K |
2014 Q1
1 quarter
|
|
|
RRTS
129
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $5.54M | 0.13% |
7,883
-10
| -0.1% | -$6.5K |
2013 Q2
4 quarters
|
|
130
Middleby
MIDD
$4.91B
| $5.44M | 0.13% |
65,760
+11,175
| +20% | +$920K |
2013 Q2
4 quarters
|
|
131
Harley-Davidson
HOG
$2.87B
| $5.24M | 0.12% |
75,070
| – | – |
2013 Q2
4 quarters
|
|
|
SYNT
132
DELISTED
Syntel Inc
SYNT
| $5.08M | 0.12% |
118,260
+22,210
| +23% | +$914K |
2013 Q2
4 quarters
|
|
|
CXO
133
DELISTED
CONCHO RESOURCES INC.
CXO
| $5.06M | 0.12% |
35,040
-10,000
| -22% | -$1.33M |
2013 Q2
4 quarters
|
|
134
WEX
WEX
$6.17B
| $5.03M | 0.12% |
47,875
+70
| +0.1% | +$6.69K |
2013 Q2
4 quarters
|
|
135
Marsh
MRSH
$89B
| $4.95M | 0.12% |
95,480
-36,035
| -27% | -$1.79M |
2013 Q2
4 quarters
|
|
136
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $4.84M | 0.11% |
116,085
-155
| -0.1% | -$5.92K |
2013 Q4
2 quarters
|
|
137
Jack Henry & Associates
JKHY
$11B
| $4.8M | 0.11% |
80,820
+280
| +0.3% | +$16K |
2013 Q2
4 quarters
|
|
138
Cullen/Frost Bankers
CFR
$9.58B
| $4.77M | 0.11% |
60,060
| – | – |
2013 Q2
4 quarters
|
|
139
Fortinet
FTNT
$133B
| $4.76M | 0.11% |
947,900
-1,100
| -0.1% | -$4.93K |
2013 Q4
2 quarters
|
|
140
DELISTED
Juniper Networks
JNPR
| $4.67M | 0.11% |
+190,175
| New | +$4.72M |
2014 Q2
0 quarters
|
|
|
BYI
141
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $4.65M | 0.11% |
70,715
+30
| +0% | +$1.87K |
2013 Q2
4 quarters
|
|
142
Omnicell
OMCL
$1.64B
| $4.64M | 0.11% |
161,565
-160
| -0.1% | -$4.32K |
2013 Q2
4 quarters
|
|
|
SIRO
143
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $4.57M | 0.11% |
55,480
+225
| +0.4% | +$17.1K |
2013 Q2
4 quarters
|
|
144
BorgWarner
BWA
$11.9B
| $4.57M | 0.11% |
79,634
| – | – |
2013 Q2
4 quarters
|
|
145
Regal Rexnord
RRX
$10.4B
| $4.56M | 0.11% |
58,070
-40
| -0.1% | -$3.04K |
2013 Q2
4 quarters
|
|
146
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $4.42M | 0.11% |
97,570
+4,870
| +5% | +$211K |
2013 Q2
4 quarters
|
|
147
Marten Transport
MRTN
$1.05B
| $4.39M | 0.1% |
491,130
-700
| -0.1% | -$6.39K |
2013 Q2
4 quarters
|
|
148
Euronet Worldwide
EEFT
$2.45B
| $4.38M | 0.1% |
90,860
-25,330
| -22% | -$1.15M |
2013 Q2
4 quarters
|
|
149
Carriage Services
CSV
$574M
| $4.32M | 0.1% |
252,415
+9,965
| +4% | +$172K |
2013 Q3
3 quarters
|
|
150
Generac Holdings
GNRC
$11.7B
| $4.31M | 0.1% |
88,355
+5,125
| +6% | +$270K |
2013 Q2
4 quarters
|
|
Similar funds
SCM
Nicholas Company's Q2 2014 Portfolio in Review
As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
- Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
- Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
- Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
- Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
- Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
- Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.
Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.